Pharmacokinetics and Bioequivalence of Branded and Generic Formulations of Dofetilide 0.5‐mg Capsules After Single‐Dose Administration in Healthy Subjects

导出原文传递

翻译打印收藏纠错

作者： VanderLugt James T. ^[1] ; Bon Charles ^[2] ; Knuth Dean ^[3] ; Schreiber Rhonda ^[4] ; Ruff Michael D.

作者单位： Biostudy Solutions, LLCWilmington,NC,USA ^[1] MPI ResearchMattawan,MI,USA ^[2] Mayne Pharma, Inc.Greenville,NC,USA ^[3] Jasper Clinic, IncKalamazoo,MI,USA ^[4]

关键词 antiarrhythmia bioequivalence dofetilide TIKOSYN atrial fibrillation

发布时间 2018-08-14

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Clinical pharmacology in drug development

2018年7卷3期

311-318页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Pharmacokinetics and Bioequivalence of Branded and Generic Formulations of Dofetilide 0.5‐mg Capsules After Single‐Dose Administration in Healthy Subjects

Clinical pharmacology in drug development

相似文献

Clinical pharmacology in drug development

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Pharmacokinetics and Bioequivalence of Branded and Generic Formulations of Dofetilide 0.5‐mg Capsules After Single‐Dose Administration in Healthy Subjects

Clinical pharmacology in drug development

相似文献

Clinical pharmacology in drug development

相关期刊

检索历史清除